A Trial Evaluating the Efficacy of Ivonescimab in Metastatic Endocrine Refractory HR-positive HER2-negative or Triple Negative Invasive Lobular Carcinoma
for
Metastatic Endocrine Refractory,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07229417
Phase2, Recruiting
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
for
Type 1 Diabetes (T1D), Metabolic Diseases,
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18 - 69
Code: NCT07699380
Phase2, Recruiting
Implementation of Support in the Care of Adults Living With Type 1 Diabetes
for
Type 1 Diabetes, Metabolic Disease, Endocrine System Diseases,
Location: Quebec, Montreal, Terrebonne
Sponsor: McGill University
Sex: All
Age: 18+
Code: NCT06069583
Recruiting
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies